Neuroquell products recalled over current good manufacturing practice violations
Neuroquell and Neuroquell Plus, 0.22 fl oz, distributed by Claire Ellen Products, are recalled for cGMP violations. 72 containers sold via the internet are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Rubric level 2 covers precautionary recalls; the notice cites manufacturing practice violations without describing any defect or health consequence.
Plain-English summary
Neuroquell and Neuroquell Plus, 0.22 fl oz (6.6 mL), manufactured for and distributed by Claire Ellen Products of Westboro, Massachusetts, NDC 66233712-01, are being recalled. Affected codes include lot B-02, batch 1087920520 and batch 1087920920, product number R937, with a best-before date of May 31, 2021. The recall covers 72 containers distributed via the internet.
The recall was issued for current good manufacturing practice violations. The FDA classified the action as Class II. The notice does not describe a specific defect in the product.
Anyone holding this product should stop using it and follow the distributor's instructions for return.
The recalled product
- Product
- Neuroquell & Neuroquell Plus, .22 fl. Oz (6.6mL),Mfg. For/Dist. By Claire Ellen Products, P.O. Box 901 Westboro, MA 01581 USA, NDC 66233712-01
- Manufacturer
- Atlantic Management Resources Ltd.
- Category
- Drug — Topical
- Hazard
- cgmp-violation
- class-ii
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # B-02 Batch #: 1087920520 Product # R937 BBE#31-05-21( May 31
- 2021) Batch # 1087920920 Product # R937 BBE# 31-05-21 (May 31
- 2021)
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- SevereMajor Pharmaceuticals Recalls Levothyroxine Sodium Tablets Over Subpotency
FDA (Drugs) · 2026-07-29
- HighLevothyroxine Sodium Tablets Recalled Due to Subpotent Drug Concerns
FDA (Drugs) · 2026-07-29
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29